15 minute intraday candlestick chart, ~15 minute delayCurrently unavailable for this symbol.
Try again later today or try daily, weekly, monthly or quarterly charts.
15 minute intraday candlestick chart, ~15 minute delayCurrently unavailable for this symbol.
Try again later today or try daily, weekly, monthly or quarterly charts.
EXAS News
3-Feb-2025 5:00 AM CST - Business Wire Exact Sciences Schedules Fourth Quarter 2024 Earnings Call Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2024 financial results after the close of the U.S. financial markets on February 19, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Fourth quarter 2024 webcast & conference call details Date
12-Jan-2025 6:00 PM CST - Business Wire Exact Sciences Announces Preliminary Fourth Quarter 2024 Results Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ended December 31, 2024. "The Exact Sciences team delivered strong results to finish 2024, setting us up for sustained growth and profitability in the years to come," said Kevin Conroy, chairman and CEO. "We look forward to expanding our impact as the platform supporting
2-Jan-2025 5:00 AM CST - Business Wire Exact Sciences to Participate in J.P. Morgan Healthcare Conference Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. J.P. Morgan Healthcare Conference, San Francisco Presentation followed by Q&A on Monday, January 13, 2025 at 1:30 p.m. ET The webcast can be accessed in the investor relations section of Exact Sciences website at www.exactsciences
26-Nov-2024 5:00 AM CST - Business Wire Exact Sciences to Participate in December Investor Conferences Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. Citi Global Healthcare Conference, Miami Fireside chat on Tuesday, December 3, 2024 at 8:45 a.m. ET Evercore HealthCONx Conference, Miami Fireside chat on Wednesday, December 4, 2024 at 7:30 a.m. ET The webcasts can be accessed in the
5-Nov-2024 3:05 PM CST - Business Wire Exact Sciences Announces Third-Quarter 2024 Results Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $709 million for the third quarter ended September 30, 2024, compared to $628 million for the same period of 2023. The Exact Sciences team is helping eradicate cancer while strengthening our platform and growing our business efficiently, said Kevin Conroy, chairman and CEO. During the third quarter, we deliver
1-Nov-2024 5:00 AM CST - Business Wire Exact Sciences to Participate in November Investor Conference Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. Jefferies London Healthcare Conference, London Fireside chat on Tuesday, November 19, 2024 at 6:00 a.m. ET The webcast can be accessed in the investor relations section of Exact Sciences website at www.exactsciences.com. About Exact S
8-Oct-2024 5:00 AM CST - Business Wire Exact Sciences Schedules Third Quarter 2024 Earnings Call Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2024 financial results after the close of the U.S. financial markets on November 5, 2024. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Third quarter 2024 webcast & conference call details
Latest EXAS Trades by Congress Members
10-MAY-2024 - Josh Gottheimer, NJ (District 5) sold between $1,001 and $15,000.
3-Feb-2025 5:00 AM CST - Business Wire Exact Sciences Schedules Fourth Quarter 2024 Earnings Call Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2024 financial results after the close of the U.S. financial markets on February 19, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Fourth quarter 2024 webcast & conference call details Date
12-Jan-2025 6:00 PM CST - Business Wire Exact Sciences Announces Preliminary Fourth Quarter 2024 Results Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ended December 31, 2024. "The Exact Sciences team delivered strong results to finish 2024, setting us up for sustained growth and profitability in the years to come," said Kevin Conroy, chairman and CEO. "We look forward to expanding our impact as the platform supporting
2-Jan-2025 5:00 AM CST - Business Wire Exact Sciences to Participate in J.P. Morgan Healthcare Conference Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. J.P. Morgan Healthcare Conference, San Francisco Presentation followed by Q&A on Monday, January 13, 2025 at 1:30 p.m. ET The webcast can be accessed in the investor relations section of Exact Sciences website at www.exactsciences
26-Nov-2024 5:00 AM CST - Business Wire Exact Sciences to Participate in December Investor Conferences Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. Citi Global Healthcare Conference, Miami Fireside chat on Tuesday, December 3, 2024 at 8:45 a.m. ET Evercore HealthCONx Conference, Miami Fireside chat on Wednesday, December 4, 2024 at 7:30 a.m. ET The webcasts can be accessed in the
5-Nov-2024 3:05 PM CST - Business Wire Exact Sciences Announces Third-Quarter 2024 Results Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $709 million for the third quarter ended September 30, 2024, compared to $628 million for the same period of 2023. The Exact Sciences team is helping eradicate cancer while strengthening our platform and growing our business efficiently, said Kevin Conroy, chairman and CEO. During the third quarter, we deliver
1-Nov-2024 5:00 AM CST - Business Wire Exact Sciences to Participate in November Investor Conference Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. Jefferies London Healthcare Conference, London Fireside chat on Tuesday, November 19, 2024 at 6:00 a.m. ET The webcast can be accessed in the investor relations section of Exact Sciences website at www.exactsciences.com. About Exact S
8-Oct-2024 5:00 AM CST - Business Wire Exact Sciences Schedules Third Quarter 2024 Earnings Call Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2024 financial results after the close of the U.S. financial markets on November 5, 2024. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Third quarter 2024 webcast & conference call details